Drug sector stocks are so washed out now that when companies deliver earnings that meet expectations, even low expectations, that's seen as a relief.

Lilly to us is going to emerge as the drug company of the decade.

There's isolated incidents of companies (warning) because of patent expiration or pipeline problems or both, but they are very isolated.

Warner-Lambert is trying to maximize the price paid for the company. They think that they are entitled to a higher price, and this facilitates that.

We had the absolute perfect storm of college football. The absolute delight is that the game exceeded expectations. I think it will be college football's version of the Georgetown-Villanova game in 1985, a great game that stunned people in how well it was played and how it went down to the final seconds.

We believe that the industry is only at the initial phases of what we think will be a very significant consolidation.